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Dishevelled has a YAP nuclear export function in a
tumor suppressor context-dependent manner
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Phosphorylation-dependent YAP translocation is a well-known intracellular mechanism of the
Hippo pathway; however, the molecular effectors governing YAP cytoplasmic translocation
remains undeﬁned. Recent ﬁndings indicate that oncogenic YAP paradoxically suppresses
Wnt activity. Here, we show that Wnt scaffolding protein Dishevelled (DVL) is responsible
for cytosolic translocation of phosphorylated YAP. Mutational inactivation of the nuclear
export signal embedded in DVL leads to nuclear YAP retention, with an increase in TEAD
transcriptional activity. DVL is also required for YAP subcellular localization induced by E-
cadherin, α-catenin, or AMPK activation. Importantly, the nuclear-cytoplasmic trafﬁcking is
dependent on the p53-Lats2 or LKB1-AMPK tumor suppressor axes, which determine YAP
phosphorylation status. In vivo and clinical data support that the loss of p53 or LKB1 relieves
DVL-linked reciprocal inhibition between the Wnt and nuclear YAP activity. Our observations
provide mechanistic insights into controlled proliferation coupled with epithelial polarity
during development and human cancer.
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The Hippo signaling is an evolutionary conserved pathwaythat inhibits cell proliferation by contact inhibition, its lossleading to both organ growth and cancer development. The
Yes-associated protein (YAP) transcription co-activator is a key
regulator of the Hippo pathway1,2. Inhibition of the Hippo
pathway leads to increased nuclear YAP abundance and TEAD
transcriptional activity, resulting in increased organ size as well as
overgrowth of cancer3,4. Conversely, activation of the Hippo
pathway induced by cell-to-cell contact leads to phosphorylation
and inhibition of nuclear YAP. In mammals, large tumor sup-
pressor (Lats)1/2 serine/threonine kinase phosphorylates at
multiple sites on YAP, including Ser127, resulting in cytoplasmic
translocation from the nucleus1,5,6. Recently, AMP-activated
protein kinase (AMPK) has been shown to directly phosphor-
ylate YAP, resulting in cytoplasmic retention and suppression of
nuclear YAP activity7,8. While the phosphorylation-dependent
YAP shuttling is critically important in the Hippo pathway and/
or in metabolic regulation, the molecular effector of the dynamic
intracellular shuttling is not known.
The canonical Wnt pathway comprises fundamental extra-
cellular signaling involving diverse developmental process, and
deregulation of components involved in the Wnt/β-catenin
pathway has been implicated in a wide spectrum of diseases,
particularly human cancers9. Highly conserved in metazoan, the
Wnt signaling is critically important for coordinative regulation
of cell-to-cell adhesion from cell membrane to transcriptional
activity in the nucleus. The β-catenin, a key mediator of Wnt
signaling, functions both as intercellular adhesion complex
through binding to cytoplasmic domain of E-cadherin and as
transcriptional co-activator in the nucleus with T-cell factor/
lymphoid enhancer factor (TCF/LEF)9,10. Because the Hippo and
Wnt pathways similarly regulate intercellular adhesion and
nuclear transcriptional activity11, elucidating a reciprocal link
between the two pathways may reveal an important molecular
mechanism in human cancer and other diseases. Although the co-
activation of Wnt signaling and YAP activity are commonly
observed in human cancer, recent ﬁndings point to a dilemma in
that YAP suppresses canonical Wnt via binding to Dishevelled
(DVL) and/or β-catenin2,12–15. Although a large body of studies
have focused on YAP regulation of canonical Wnt activity in
development and cancer12–14, the upstream function and mole-
cular mechanisms enabling reciprocal regulations between YAP
and Wnt signaling are largely unknown16.
In this study, we found that DVL, a scaffolding protein of the
Wnt pathway as well as a key regulator of Wnt-independent
epithelial polarity, is a molecular effector for nuclear-cytoplasmic
shuttling of YAP in a YAP phosphorylation-dependent manner.
Furthermore, oncogenic inactivation of p53/Lats2 and the liver
kinase B1 (LKB1)/AMPK tumor suppressor axes, two most
commonly observed genetic alterations in human cancer, abolish
DVL’s function on YAP nuclear export. The loss of tumor sup-
pressor function allows co-activation of the canonical Wnt
pathway and nuclear YAP activity by DVL. Our observations
demonstrate molecular mechanisms for the dynamic regulation
of YAP activity via subcellular trafﬁcking by DVL as well as the
importance of p53 and LKB1 tumor suppressor contexts in the
reciprocal control between the canonical Wnt and Hippo
pathways.
Results
DVL interacts with YAP in a phosphorylation-dependent
manner. Because the YAP antagonizes Wnt activity via binding
to DVL in development and human cancer2,13, we focused on
roles of enigmatic DVL on YAP activity in this study. As a key
scaffolding protein of the Wnt pathway, DVL in mammal consists
of three highly similar homolog genes, DVL1, DVL2, and DVL3.
Although DVL2 has received close attention in recent develop-
mental studies due to its ubiquitous abundance in various tis-
sues17–19, differential expression patterns of DVL homologs in
human cancer have not been clearly determined20. We ﬁrst
examined the transcript abundance of DVL homologs from the
1093 breast cancer patients and found that DVL3 transcripts were
most abundant in clinical samples (Supplementary Fig. 1a).
Because the stability and protein level of DVL are controlled by
post-translational modiﬁcation with many DVL-interacting pro-
teins21, we next examined relative abundance of transcripts and
protein in human cancer cells. Consistently, DVL3 is most
abundant in the human cancer cell lines panel (Supplementary
Fig. 1b, c), indicating that DVL3 is mainly expressed in human
cancer. To examine crosstalk between Wnt and YAP, we next
explored interactions between DVL3 and YAP. Consistent with
previous observations12,13, immunoﬂuorescence assay with
endogenous DVL3 and YAP revealed that those proteins are co-
localized mainly in cytoplasm under conﬂuent condition in MCF-
10A and MCF-7 epithelial cells (Fig. 1a and Supplementary
Fig. 1d). Because the phosphorylation on multiple sites of YAP
plays key roles in its cytosolic localization5,6, we examined
potential interactions of DVL based on YAP phosphorylation
status. Co-immunoprecipitation assay with epitope-tagged pro-
teins revealed that wild-type (wt) YAP interacted with DVL3,
whereas phosphorylation-resistant mutants of YAP largely abol-
ished the interaction (Fig. 1b). To simply examine YAP
phosphorylation-dependent interaction, we treated lambda pro-
tein phosphatase (λ PPase) in vitro to immunoprecipitated YAP
and subjected it to DVL binding. The λ PPase treatment reduced
YAP phosphorylation status and ablated its DVL binding
(Fig. 1c). The Lats1/2 kinases and AMPK are well-known kinases
regulating YAP phosphorylation5–8. To further determine the
roles of these kinases in the DVL-YAP interaction, we introduced
the dominant negative mutants of Lats2 (Lats2-KR), kinase-dead
AMPK (AMPK-KD) or LKB1 mutant (LKB1-KD) with DVL3.
Indeed, the kinase-dead dominant negative mutant of Lats2 or
AMPK or LKB1 attenuated DVL-YAP interaction with decreas-
ing YAP phosphorylation as determined by mobility shift on a
phos-tag gel and pSer127-speciﬁc YAP antibody (Fig. 1d). In
physiological condition of epithelial cells, it is well-known that
contact inhibition of epithelial cells increases YAP phosphoryla-
tion. To examine interaction of endogenous YAP phosphoryla-
tion on DVL, we next compared the YAP phosphorylation status
under sparse and conﬂuent state of MCF-10A cells, and subjected
it for immunoprecipitation assay. Indeed, contact inhibition
under conﬂuent state increased endogenous YAP phosphoryla-
tion and its subsequent binding to DVL3 (Fig. 1e). TEAD (TEA
domain family member) transcription factor functions to retain
YAP in nucleus, while 14-3-3 inhibits nuclear YAP activity via
cytoplasmic retention of phosphorylated YAP2. We, therefore,
compared the ability of DVL to bind TEAD or 14-3-3, and found
that DVL interacted with 14-3-3 (Supplementary Fig. 2a). How-
ever, DVL did not bind to TEAD while the TEAD interacted with
YAP, which served as a positive control for TEAD binding
(Supplementary Fig. 2b). In an immunoﬂuorescence study, TEAD
and DVL3 were differentially localized in nucleus and cytoplasm,
respectively. These results indicate that DVL mainly interacts
with cytoplasmic YAP in a phosphorylation-dependent manner.
DVL suppresses YAP nuclear abundance and TEAD activity.
Although recent studies have focused on the role of YAP in
antagonizing Wnt activity, the upstream functions by which the
Wnt scaffolding protein affect nuclear YAP and TEAD tran-
scriptional activity have not been widely studied. To address the
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upstream role of DVL, we overexpressed DVL3 and measured
TEAD transcriptional activity with a synthetic reporter construct
containing multimerized responsive elements of TEAD. Inter-
estingly, DVL3, as well as DVL1 or DVL2, signiﬁcantly sup-
pressed TEAD transcriptional activity although the total protein
abundance of YAP increased slightly in MCF-7 and 293 cells
(Fig. 2a and Supplementary Fig. 3a, b). Similarly, DVL3 sup-
pressed TEAD transcriptional activity and transcript abundance
of CTGF (Fig. 2a), a representative transcription target of the
YAP/TEAD complex, suggesting that DVL inhibits nuclear YAP
transcriptional activity in cells. Given observations that DVL
interacts with phosphorylated YAP, we hypothesized that DVL
controls nuclear YAP activity via intracellular dynamics rather
than by regulating YAP abundance. To prove this notion directly,
cells were transfected with DVL3 expression vector and the
nuclear YAP compartmentalization was assessed. Indeed,
DVL3 signiﬁcantly depleted nuclear YAP abundance in 293 and
MCF-7 cells (Fig. 2b). The YAP has multiple phosphorylation
sites involving cytoplasmic retention and protein stability of
YAP5,6, and Ser127 phosphorylation is required for cytoplasmic
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Fig. 1 DVL interacts with phosphorylated YAP. a Confocal images of endogenous YAP (green) and DVL3 (red) in MCF-10A cells. Arrows indicate co-
localized foci. Nuclear staining with TOPRO3 (blue) is shown in merged image. Scale bar, 10 μm. b DVL interacts with YAP in a phosphorylation-dependent
manner. In all, 293 cells were transfected with His-tagged DVL3 and vector control (−) or ﬂag-tagged YAP or mutants (5SA, S127A). Interactions between
DVL and YAP were determined following immunoprecipitation (IP) with anti-ﬂag antibody and immunoblotting with anti-HA. Whole-cell lysate (WCL)
serves as input abundance for IP. c Lambda protein phosphatase (λ PPase) treatment to immunoprecipitated YAP abolishes DVL binding. The 293 cells
were transfected with ﬂag-tagged YAP and immunoprecipitated anti-ﬂag beads were treated with λ PPase (+). The agarose beads were then subjected to
binding to HA-tagged DVL. d Kinase-dead dominant negative Lats2 (Lats2-KR) or AMPK (AMPK-KD) or LKB1 (LKB1-KD) abolishes YAP and DVL
interaction. Flag-tagged YAP and His-tagged DVL3 expression vectors were co-transfected with the dominant negative expression vectors as indicated in
293 cells. Interactions between DVL3 and YAP were determined as described above and phosphorylation status of YAP was determined by pS127-YAP
antibody and mobility shift on a phos-tag gel. Black and red arrowheads correspond to the fully phosphorylated and active YAP on a phos-tag gel,
respectively. e The MCF-10A cells were cultured under sparse and conﬂuent states, and the whole-cell lysates (WCL) were subjected for immunoblot
analysis and immunoprecipitation (IP) assay with anti-YAP antibody. Mouse IgG served as negative control. Unprocessed original scans of blots are shown
in Supplementary Fig. 10
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Fig. 2 DVL suppresses YAP nuclear abundance and TEAD transcriptional activity. a YAP was co-transfected with HA-DVL3 into MCF-7 cells, and protein
abundance (left), TEAD reporter activity (right upper), and CTGF transcript abundance (right lower) were determined. Data of reporter assay and RT-PCR
are normalized to negative control empty vector (−) and presented as mean ± SD. b The 293 and MCF-7 cells were transfected with DVL3, and protein
abundance of YAP in nuclear and cytoplasmic fraction was determined by immunoblot analysis. YAP phosphorylation status in cytoplasmic and nuclear
fraction was determined by pS127-YAP antibody and mobility shift on a phos-tag gel. Red arrowhead indicates active YAP on a phos-tag gel. Tubulin and
HDAC1 served as loading controls of cytosolic fraction and nuclear lysates, respectively. Relative nuclear YAP abundance compared to control was
measured by ImageJ. c, d Inducible knockdown of DVL3 increases nuclear YAP abundance. The MCF-10A cells expressing tetracycline-inducible shRNA
against DVL3 were generated with lentiviral system, and endogenous YAP localization and abundance without or with doxycycline (Dox) were determined
by immunoﬂuorescence (c) and immunoblot analysis from whole-cell lysate (WCL) and nuclear fraction (d). The cells were serum-starved for 16 h before
harvest. Tubulin and HDAC1 served as loading controls of cytosolic fraction and nuclear lysates, respectively. e DVL3 was knockdowned with doxycycline
(Dox), and the TEAD reporter activity (upper panel) and CTGF transcript abundance (lower panel) were determined by reporter assay and qRT-PCR,
respectively. f The wt and DVL-TKO cells were cultured in conﬂuent condition and subcellular localization of endogenous YAP and DVL3 were determined
by confocal microscopy (left panels) and immunoblot analysis (right panels). The cells were serum-starved for 16 h before examination. Inset, DAPI nuclear
stain; Scale bar, 10 μm. g Knockdown of DVL3 increases anchorage-independent growth of MCF-7 cells. The MCF-7 cells expressing inducible shRNA for
DVL3 were seeded onto a soft agar without (Dox-) or with (Dox+) doxycycline in combination with shControl or shYAP for 3 weeks. The colonies were
stained with crystal violet and quantiﬁed. Data presented as mean ± SD, n= 5
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translocation of YAP5. Consistently, nuclear YAP was unpho-
sphorylated regardless of DVL3 abundance as determined by
pSer127-YAP antibody and mobility shift on a phos-tag gel. TAZ
(transcriptional co-activator with a PDZ-binding motif), YAP
homolog and an integral member of the Hippo pathway, binds
DVL12. When we examined the effect of DVL on TAZ, the DVL
also interacted with TAZ and suppressed nuclear TAZ abun-
dance, TEAD transcriptional activity indicating the critical
function of DVL on the Hippo pathway (Supplementary Fig. 3c).
To further determine the role of endogenous DVL, we made
inducible shRNA constructs against DVL3 and examined nuclear
YAP abundance. The cytoplasmic translocation of YAP by con-
tact inhibition is a well-known intracellular mechanism of the
Hippo pathway5,6. When we cultured conﬂuent epithelial MCF-
10A or MCF-7 cells, contact inhibition led to cytoplasmic
translocation of YAP while inducible knockdown of DVL3 largely
increased its nuclear retention (Fig. 2c and Supplementary
Fig. 4a). Interestingly, the nuclear YAP remained unpho-
sphorylated although nuclear YAP abundance was increased by
the loss of endogenous DVL3 (Fig. 2d). These results indicate that
endogenous DVL is required for cytoplasmic translocation of
Ser127 phosphorylated YAP and nuclear YAP remains active
regardless of DVL abundance. DVL’s role in YAP nuclear
retention was functional in terms of TEAD reporter activity and
CTGF transcript abundance (Fig. 2e). To unambiguously estab-
lish DVL as a critical effector of YAP trafﬁcking, we next used wt
and DVL1/2/3-triple knockout (DVL-TKO) 293 T-REx cells to
examine endogenous YAP localization22. In every case, YAP
largely remained in the nuclear space in DVL-TKO cells under
conﬂuent contact inhibition while the YAP phosphorylation
status was unchanged by knockout of DVLs (Fig. 2f). Re-
introduction of wt DVL3 into DVL-TKO cells successfully res-
cued YAP translocation into cytoplasmic space (Supplementary
Fig. 4b). The effect of nuclear YAP on oncogenic transformation
having been clearly demonstrated by anchorage-independent
growth assay6,8, we thus next examined the effect of such DVL-
mediated nuclear YAP on oncogenic transformation. Knockdown
of DVL3 was sufﬁcient to increase the transforming potential of
MCF-7 cells in a YAP-dependent manner (Fig. 2g). These
observations indicate that DVL regulates nuclear abundance and
transcriptional activity of YAP.
DVL enables YAP nuclear export. To elucidate the mechanistic
link between DVL and nuclear YAP activity, we next examined
the inﬂuence of DVL’s conserved domains on YAP interaction.
The DVL has several conserved domains, an N-terminal DIX, a
central PDZ, and a C-terminal DEP, all implicated in mediating
many cellular functions with variable interacting partners23. To
test whether these domains are responsible for nuclear YAP
activity, we made deletion constructs and tested the ability of
DVL mutants to redirect YAP localization. However, deletion
mutants of those conserved domains suppressed nuclear YAP
abundance and TEAD transcriptional activity, the deletion
mutants of DVL3 retaining binding ability to YAP (Supplemen-
tary Fig. 5a). In the C-terminus of YAP, there is a PDZ-binding
motif required for interaction with YAP binding proteins having
the PDZ domain24. Indeed, deletion of the PDZ-binding motif
ablated YAP binding to DVL (Supplementary Fig. 5b). SET7
(SETD7)-mediated monomethylation of lysine 494, located close
to the PDZ-binding domain, has been identiﬁed as critical for
cytoplasmic localization of YAP despite S127 phosphorylation25.
To determine the role of lysine monomethylation, we made a
K494R mutant of YAP and subjected it to DVL interaction.
Interestingly, a point mutant of the lysine was sufﬁcient to abolish
DVL interaction (Supplementary Fig. 5b), indicating that the
PDZ-binding domain and monomethylation may cooperate for
DVL interaction. The YAP WW domains interact with multiple
proteins, such as AMOT and ERBB426,27. To examine whether
the WW domains play a role in DVL interaction, we made a
deletion mutant of WW domains and subjected it to immuno-
precipitation assay. Interestingly, deletion of the WW domains
largely abolished DVL interaction with YAP (Supplementary
Fig. 5b). These results indicate that both WW domain and the
PDZ-binding domain are involved in DVL interaction. Given that
the PDZ domain of DVL is necessary, but not sufﬁcient, for YAP
interaction, we next examined DVL domains for YAP interaction.
Because TAZ interacts with the PY motif (PPxY) as a WW
domain-binding ligand and PDZ domain of DVL12,28, we next
made deletion mutants of the PY motif and PDZ domain of DVL
to examine the interaction of the mutants with YAP. Like TAZ,
the PDZ domain and a PY motif of DVL both contribute to YAP
interaction (Supplementary Fig. 5b). Note that deletion of the PY
motif and the PDZ domain of DVL unable to bind to YAP did
not translocate YAP into cytoplasm (Supplementary Fig. 5c),
indicating that interaction with YAP is required for DVL’s role in
YAP subcellular localization.
Scaffolding proteins in the Wnt pathway such as APC and
Axin have a nuclear export function29–31. Although DVL has
been reported to undergo nuclear-cytoplasmic shuttling of β-
catenin32, its role in YAP intracellular trafﬁcking has not yet been
determined. To test whether DVL regulates nuclear YAP
dynamics, we treated Leptomycin B (LMB), a speciﬁc inhibitor
of CRM1 (chromosomal region maintenance)/exportin 1 required
for nuclear export of proteins containing a leucine-rich nuclear
export sequence (NES). Under conﬂuent contact inhibition state,
endogenous YAP mainly localized in the cytoplasm together with
DVL (Fig. 3a). Interestingly, LMB treatment in conﬂuent MCF-7
cells led to nuclear retention of endogenous DVL and YAP
together, supporting that the nuclear export function of DVL may
regulate the nuclear-cytosolic dynamics of YAP. Interestingly, the
DVL family amino-acid sequence contains highly conserved
typical NES consisting of M/LxxLxL (capital letter Met or Leu
amino acids, where x is any amino acid) next to the DEP domain
(Fig. 3b)32. To test whether the NES of DVL is responsible for
intracellular YAP shuttling, we made a point mutant of DVL3
whose Leu in this NES was substituted with Ala (ASA mutant).
When we examined the subcellular localization of wt or ASA
point mutant DVL3, mutational inactivation of NES was
sufﬁcient to restrict DVL in nucleus (Supplementary Fig. 5d),
indicating that NES is critically required for cytoplasmic
translocation of DVL. We then made inducible wt and ASA
mutant of DVL in MCF-10A and MCF-7 cells to assess for
endogenous YAP compartmentalization with doxycycline treat-
ment. Whereas DVL and YAP were mainly co-localized in the
cytoplasm in inducible wt DVL3 cells, the induction of ASA
mutant led to distinctive nuclear retention of DVL3 and YAP
together (Fig. 3c and Supplementary Fig. 5e). When we examined
nuclear YAP level with an inducible DVL3 system, nuclear
abundance of endogenous YAP was not suppressed by the ASA
mutant DVL3 in MCF-7 and 293 cells (Fig. 3d). As with
knockdown of DVL3, induction of ASA mutant did not affect
nuclear YAP phosphorylation status. Given DVL’s interaction
with phosphorylated YAP, we next examined whether ASA
mutant of DVL interacts with unphosphorylated YAP in nuclear
space. Interestingly, NES-mutant of DVL did not interact with
nuclear YAP (Fig. 3e). To examine whether the disruption of
DVL’s nuclear export is functional on YAP transcriptional
activity, we determined TEAD reporter activity and CTGF
transcript abundance. Consistent with increased active YAP in
nuclear space, induced expression of ASA mutant increased
TEAD reporter activity and CTGF transcript level in MCF-7 cells
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(Fig. 3f). To assess the functional importance of activation of
nuclear YAP by ASA mutant, we next performed anchorage-
independent growth assay. Consistently, YAP increased
anchorage-independent growth of MCF-7 cells and DVL
suppressed YAP-mediated soft agar growth (Fig. 3g). The ASA
mutant of DVL3 rescued the wt DVL function on YAP-mediated
anchorage-independent growth. To validate nuclear export of
YAP by DVL in vivo, we next made tumors of 293 cells
expressing inducible wt or ASA mutant DVL3 and examined
YAP localization from xenografted tissue. Indeed, YAP was
mainly localized in cytoplasmic and nuclear space by induction of
wt or ASA mutant DVL3, respectively, (Fig. 3h). Thus, the
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nuclear export function of DVL is responsible for intracellular
trafﬁcking and YAP transcriptional activity.
Phosphorylation-dependent YAP nuclear export by DVL.
Given the YAP phosphorylation-dependent binding of DVL, we
next examined how YAP phosphorylation status affected DVL’s
nuclear export function. To examine the effect of YAP phos-
phorylation on DVL’s function, we next assessed DVL suppres-
sion of YAP phosphorylation-resistant mutants. Indeed, the
suppressor role of DVL3 by means of TEAD reporter activity and
nuclear YAP abundance was largely abolished in the YAP
phosphorylation-resistant mutants (Fig. 4a). In an immuno-
ﬂuorescence study, wt YAP consistently co-localized with DVL3
mainly in cytoplasm (Fig. 4b). However, the phosphorylation-
resistant mutants of YAP were localized in nuclear space inde-
pendent of DVL3. Because the Lats1/2 are well-known kinases of
YAP phosphorylation at multiple sites, we transfected the kinase-
dead dominant negative Lats2 and examined the extent to which
DVL suppressed TEAD transcriptional activity. Interestingly,
dominant negative Lats2 largely abolished DVL suppression of
YAP transcriptional activity (Fig. 4c), suggesting that the nuclear
export function of DVL depends on YAP phosphorylation. To
unambiguously establish Lats kinases as critical regulators of
DVL-mediated YAP translocation, we used Lats1/2 double-
knockout (Lats1/2−/−) mouse embryonic ﬁbroblast (MEF) and
293A cells. When we induced DVL3 in these cells, the nuclear
YAP abundance in the Lats1/2−/− cells were not decreased by
DVL3 (Fig. 4d and Supplementary Fig. 6). Therefore, DVL, a
well-known scaffolding protein of the Wnt pathway and a reg-
ulator of epithelial cell polarity, is a molecular effector of the
Hippo pathway regulating nuclear export of phosphorylated YAP
(Fig. 4e).
Wnt ligands, essential morphogens in receptor-mediated
signaling pathways, control development and tissue homeostasis.
Hyperactivation of the Wnt pathway is frequently observed in
many types of human cancer33,34. Recent studies have uncovered
the interaction between YAP/TAZ and Wnt signaling, with DVL
emerging as the hub that integrates YAP and Wnt12,13.
Intriguingly, Wnt ligands promote YAP activation via the
alternative Wnt pathway in a Lats-dependent manner35. To
examine the role of DVL in Wnt-mediated YAP regulation, we
treated soluble Wnt ligands and examined the YAP phosphor-
ylation status. Indeed, treatment with Wnt1 and Wnt3a ligands
increased active YAP resulting from decreased YAP phosphor-
ylation (Fig. 4f). Consistent with YAP phosphorylation-
dependent binding to DVL, soluble Wnt ligands treatment
decreased DVL-YAP binding. Examining endogenous YAP and
DVL localization, we found that soluble Wnt1 and Wnt3a ligands
induced nuclear YAP localization while the endogenous DVL3
largely remained in cytoplasmic space (Fig. 4g). These results
suggest that Wnt ligand activates YAP by inhibiting YAP
phosphorylation, resulting in nuclear translocation of YAP
subsequent to its release from DVL.
DVL’s role for YAP localization by adherens junction. During
the contact inhibition of epithelial cells, the E-cadherin/α-catenin
complex, well-known members of the adherens junction, plays a
critical role in the phosphorylation and cytosolic translocation of
YAP via sensing cell contact36–38. To test whether DVL is
required for E-cadherin or α-catenin-induced YAP translocation,
we next assessed the role of DVL in YAP translocation induced by
E-cadherin or α-catenin. We depleted endogenous DVL using
DVL-TKO 293 T-REx cells or shRNA-mediated knockdown of
DVL3. In an immunoﬂuorescence study, E-cadherin or α-catenin
translocated YAP into cytoplasm in wt cells while loss of endo-
genous DVL in DVL-TKO cells or by shRNA-mediated knock-
down largely retained YAP in nuclear space (Fig. 5a and
Supplementary Fig. 7a). Consistently, overexpression of E-
cadherin or α-catenin decreased TEAD reporter activity and
nuclear YAP abundance while loss of DVL largely abolished those
effects (Fig. 5b and Supplementary Fig. 7b). To further examine
the contribution of DVL induced by the endogenous adherens
junction complex, we next used a function-blocking antibody
(HECD) to disrupt E-cadherin homophilic binding in DVL-
inducible MCF-10A cells. As shown earlier, contact inhibition
under conﬂuent culture condition led to YAP cytoplasmic
retention and functional blocking of E-cadherin with HECD-
induced YAP translocation into nuclear space, while inducible
DVL3 largely abolished the HECD effect on YAP (Fig. 5c). These
results support the critical role of DVL in cytoplasmic translo-
cation of YAP regulated by E-cadherin/α-catenin complex.
Loss of p53/Lats axis relieves YAP restriction by DVL. Genetic
analysis of DVL in a developmental system has shown it to be a
potent activator of canonical Wnt signaling39. While YAP is
regarded as an oncogene in many cancers, recent observations
have indicated a tumor suppressor role of cytosolic YAP by
restriction of canonical Wnt12–14. To resolve this paradox, we
next examined the effects of upstream signals of YAP phos-
phorylation with respect to DVL’s nuclear export function. Pre-
viously, Lats2 has been identiﬁed as a direct transcriptional target
of p5340, suggesting that the p53/Lats2 tumor suppressor axis
provides a context for reciprocal regulation of canonical Wnt and
YAP by DVL. To test this idea, we knockdowned wt p53 function
and examined DVL’s affect on nuclear YAP and canonical Wnt
activity. Indeed, knockdown of p53 using shRNA or HPV
Fig. 3 NES (nuclear export sequence) in DVL is responsible for YAP trafﬁcking. a The conﬂuent MCF-7 cells were treated with Leptomycin B (LMB, 5 ngml−1)
for 4 h, and endogenous YAP and DVL localization and abundance were determined by confocal microscopy (left panels) and immunoblotting (right
panels). Scale bar, 10 μm. b Schematic representation of the conserved NES and point mutant (NES-mutant-ASA) in DVL of human (h), mouse (m), and
xenopus (x). c The MCF-7 cells were transfected with wt or NES-ASA mutant DVL3 and DVL-YAP localization was determined by confocal microscopy.
The cells were serum-starved for 16 h before harvest. Scale bar, 5 μm. d MCF-7 and 293 cells expressing inducible HA-tagged wt or NES-mutant (ASA) of
DVL3 were treated with doxycycline, and YAP and DVL abundance were determined (left panels). YAP phosphorylation status in cytoplasmic and nuclear
fraction was determined by pS127-YAP antibody and mobility shift on a phos-tag gel (right panels). Red arrowhead indicates active YAP. e The 293 cells
were transfected with ﬂag-tagged YAP with NES-mutant or wt DVL3. The nuclear protein form NES-mutant transfectant was subjected for
immunoprecipitation, whole-cell lysate of wt DVL serving as control. Fifty micro grams of nuclear protein and 10 μg of whole-cell lysates were used for
immunoprecipitation assay to adjust YAP abundance. f TEAD reporter activity and CTGF transcript abundance were analyzed from MCF-7 cells expressing
inducible wt or NES-mutant of DVL3 (mean ± SD, n= 3). g The MCF-7 cells were transfected with YAP in combination with wt or NES-ASA mutant of
DVL3, then seeded onto a soft agar for 3 weeks. The colonies were stained with crystal violet and quantiﬁed (mean ± SD, n= 5). h The 293 cells stably
expressing tet-inducible wt or NES-mutant of DVL were injected into athymic nude mice subcutaneously. When the tumor volume reached around 500
mm3 (n= 1), the mice were treated with doxycycline (50mg/kg) intraperitoneally prior sacriﬁce to 24 h. The tissues were examined by H/E staining (scale
bar, 50 μm) and YAP localization was determined from frozen sections (scale bar, 10 μm). Unprocessed original scans of blots are shown in Supplementary
Fig. 10
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Fig. 4 DVL has nuclear export function on phosphorylated YAP. a Relative fold repression of reporter activities and nuclear YAP abundance by DVL on wt
or phospho-resistant mutants of YAP (S127A, 5SA) were measured with TEAD reporter assay (left panel) and immunoblot analysis (right panels),
respectively. Relative nuclear YAP abundance compared to control was measured by ImageJ. b The MCF-7 cells were transfected with HA-tagged DVL3 in
combination with ﬂag-tagged wt or phospho-resistant mutants YAP (S127A, 5SA), and nuclear localizations of YAP and DVL were examined by confocal
immunoﬂuorescence microscopy. To minimize the overexpression issue, 10 ng of YAP expression vectors was used. Scale bar, 10 μm. c YAP and DVL3
were co-transfected in combination with vector control or dominant negative Lats2 (Lats2-KR), and relative TEAD reporter activity was measured. Data
presented as mean ± SD, n= 3. d DVL3 was transfected in wt or Lats1/2 double-knockout (Lats1/2−/−) 293A cells, and nuclear YAP abundance by DVL3
was determined by immunoblot analysis (left panels) and immunoﬂuorescence study (right panels). The cells were serum-starved for 16 h before harvest.
e Schematic diagram of nuclear export of phosphorylated YAP by DVL. f Wnt ligands activate YAP resulting in decreased interaction with DVL. The 293A
cells transfected with HA-tagged DVL3 were serum-starved and then stimulated by Wnt1 and Wnt3a ligands for 4 h. The whole-cell lysates (WCL) were
subjected for immunoblot analysis and immunoprecipitation (IP) assay with anti-HA antibody. g Soluble Wnt1 and Wnt3a induce YAP nuclear localization.
The conﬂuent 293A cells were serum-starved and then stimulated by Wnt ligands for 4 h. Endogenous YAP and DVL localization were determined by
confocal immunoﬂuorescence microscopy. Scale bar, 10 μm. Unprocessed original scans of blots are shown in Supplementary Fig. 10
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04757-w
8 NATURE COMMUNICATIONS |  (2018) 9:2301 | DOI: 10.1038/s41467-018-04757-w |www.nature.com/naturecommunications
(human papilloma virus)-E6 resulted in suppression of Lats2
protein abundance and a subsequent decrease in YAP phos-
phorylation (Fig. 6a and Supplementary Fig. 8a). Intriguingly, the
YAP nuclear export function of DVL3 was largely abolished in
those p53-loss contexts. When we examined TEAD transcrip-
tional activity, p53 tumor suppressor context was also required
for DVL to regulate nuclear YAP activity (Fig. 6b). Importantly,
loss-of-p53 context still allowed DVL to potentially affect TCF/
LEF transcriptional activity41 (Fig. 6c).
We next examined the R175H and R273H p53 mutants,
commonly found in human cancer. These also led to decreased
abundance of Lats2 and YAP phosphorylation through their
dominant negative action (Fig. 6d). Similarly to p53 knockdown
or HPV-E6, p53 mutants abolished the DVL repression of TEAD
reporter activity (Fig. 6e). In the p53 mutant context, DVL
consistently increased the TCF/LEF transcriptional activity of
canonical Wnt (Fig. 6f). Because p53’s most important function is
to act as a transcription factor42,43, we next used an artiﬁcial
deletion mutant of the N-terminus transactivation domain
(ΔTAD) of p53 to examine the intersecting role of DVL on
YAP and Wnt41,44. Indeed, ΔTAD of p53 largely abolished DVL
suppression of nuclear YAP while preserving DVL’s potential
effect on the canonical Wnt activity (Supplementary Fig. 8b).
Therefore, our results indicate that loss of p53 relieves YAP
restriction by DVL and allows co-activation of TEAD and
canonical Wnt activities by YAP and DVL, respectively.
Examining TEAD and TCF/LEF transcriptional activities with
respect to p53 status, YAP and DVL reciprocally suppressed TCF/
LEF and TEAD activity in wt p53 context while the YAP
suppressor role of DVL3 was abolished under p53-loss context,
resulting in co-activation of TEAD and TCF/LEF activities by
YAP and DVL with a p53-loss background (Fig. 6g). YAP
inhibited tumor growth in vivo with suppression of Wnt
activity13. We, therefore, examined the functional relevance of
co-activation of those oncogenic transcriptional activities by YAP
and DVL in terms of p53 context with xenograft experiments.
Indeed, YAP in combination with DVL3 signiﬁcantly increased
the tumorigenic potential of 293 cells in a p53-loss context
compared to wt p53 background (Fig. 6h). These results indicate
that tumor suppressor p53 provides an important context of
antagonistic interaction between nuclear YAP and the canonical
Wnt pathway, and that the loss-of p53 in human cancer relieves
the YAP restriction allowing co-activation of those oncogenic
pathways by DVL. To further determine the effect of p53 on the
co-activation of YAP and the Wnt pathway in clinical samples,
we analyzed RNA expression data from primary human breast
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cancer (1093 samples from TCGA) and chose CTGF and Axin2
transcripts, which are representative target genes of YAP and
TCF/LEF transcriptional machinery, respectively. We grouped
the patient samples by p53 status and dichotomized them
according to CTGF and Axin2 transcript abundance (Supple-
mentary Fig. 8c). When we analyzed the co-activation of YAP and
the Wnt pathway in a patient cohort with respect to 20 years
long-term survival, we found that increased abundance of CTGF
and Axin2 was associated with worse prognosis in mutant p53
patients while the association was inverted in the wt p53 group
(Fig. 6i), indicating the importance of p53 tumor suppressor
context in co-activation of YAP and the canonical Wnt pathway
in human cancer.
Role of DVL in metabolic contexts. The LKB1 (also known as
STK11, serine/threonine kinase 11) is the key upstream activator
of AMPK45. The mutational inactivation of LKB1 is a well-known
genetic background of Peutz-Jeghers syndrome and is frequently
found in various human cancers46,47. The LKB1/AMPK axis is
critical to cellular energy homeostasis and epithelial polarity.
Recent ﬁndings reveal that metabolic stress increases catalytic
active AMPKα and Lats1, resulting in YAP phosphorylation and
its subsequent cytosolic translocation7,8. Given the effect of YAP
phosphorylation on DVL’s dynamics, we extended our inquiry to
metabolic regulation and the effect of DVL on YAP trafﬁcking.
We induced metabolic stress by treatment of 2-deoxy-glucose
(2DG) and metformin (Met) in MCF-10A cells, then examined
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the YAP localization with an inducible DVL3 knockdown system.
YAP was mainly localized in nuclear space under sparse culture
condition and was translocated into the cytoplasm by metabolic
stress (Fig. 7a). Importantly, YAP was retained in nuclear fol-
lowing inducible knockdown of endogenous DVL3 under meta-
bolic stress. The role of metabolic stress on YAP cytoplasmic
translocation was also defective in DVL-TKO cells (Fig. 7b),
indicating that DVL is also critically required for YAP translo-
cation induced by metabolic stress. Given the effect of LKB1/
AMPK activity on DVL interaction with YAP, we next used
dominant negative LKB1 (LKB1-KD) or AMPK (AMPK-KD) to
examine the role of DVL in nuclear YAP activity in cells. Con-
sistent with a previous observation7, LKB1-KD or AMPK-KD
increased TEAD reporter activity (Supplementary Fig. 9a).
Similarly to p53 tumor suppressor context, LKB1-KD or AMPK-
KD decreased YAP phosphorylation and subsequently abolished
DVL’s ability to suppress nuclear YAP abundance and TEAD
transcriptional activity (Fig. 7c and Supplementary Fig. 9b). The
activator function of DVL on canonical TCF/LEF transcriptional
activity was maintained in the LKB1/AMPK mutant context, as
seen in the co-activation of TEAD and TCF/LEF transcriptional
activities. To further conﬁrm the role of AMPK in DVL-mediated
YAP translocation, we compared AMPKα wt and AMPKα1/α2
double-knockout (DKO) MEFs that lack the two AMPK catalytic
subunits. Indeed, induction of DVL3 failed to translocate YAP
into cytoplasm in the AMPK DKO MEFs (Fig. 7d), indicating the
critical role of AMPKα in YAP cytoplasmic trafﬁcking by DVL.
To examine the role of endogenous LKB1 in YAP subcellular
trafﬁcking, we chose naturally LKB1-deﬁcient (but having wt p53
and E-cadherin positive) A549 non-small-cell lung cancer cells
and examined the YAP localization44,48. Indeed, YAP was dif-
fusely localized at nuclear and cytoplasmic space regardless of
cell–cell contact in epithelial A549 cells (Supplementary Fig. 9c).
Importantly, overexpression of DVL3 was inactive in terms of
YAP nuclear export in A549 cells (Fig. 7e), indicating that loss of
LKB1 tumor suppressor abolishes DVL’s YAP nuclear export
function. The tumor suppressive role of LKB1 has been clearly
demonstrated by experiments in which conditional LKB1 inac-
tivation led to neoplastic transformation in a number of tissues49.
To prove the functional relevance of LKB1 mutation context
allowing co-activation of Wnt and nuclear YAP, we next per-
formed an in vivo xenograft tumorigenic assay. Indeed, loss of
LKB1 context increased tumorigenic potential by YAP and DVL
in vivo as in the p53 tumor suppressor context (Fig. 7f).
Taken together, our results demonstrate that the intact tumor
suppressor function of p53/Lats2 or LKB1/AMPK axes is required
for inhibition of nuclear YAP by DVL. Conversely, mutational
inactivation of p53/Lats2 or LKB1/AMPK axes in human cancer
critically allows DVL to become a potent activator of the
canonical Wnt pathway without suppression of nuclear YAP
(Supplementary Fig. 9d).
Discussion
The Hippo/YAP and canonical Wnt pathways are highly con-
served signaling cascades regulating cell-to-cell interaction and
contact inhibition, and hyperactive nuclear YAP and Wnt activity
are bona ﬁde oncogenes in many types of human cancer2,4.
Moreover, the canonical Wnt and Hippo pathways are closely
connected to each other6,11. Recent studies have focused on a
molecular mechanism whereby YAP represses the Wnt activity
via interaction with β-catenin, DVL2 and the Axin-GSK-3
complex13,14,16. These observations raise the paradox of a
tumor suppressive function of cytoplasmic YAP2,15. In this study,
we show that DVL, a scaffolding protein of the canonical Wnt
pathway as well as an integral member of non-canonical planar
cell polarity (PCP) signaling, binds to phosphorylated YAP with
the PDZ domain and PY motif, subsequently regulating nuclear-
cytoplasmic trafﬁcking of YAP.
Note that other scaffolding proteins of the Wnt pathway have a
similar function. The APC (adenomatous polyposis coli) harbors
highly conserved NES, whose mutational inactivation in cancer
cells results in nuclear accumulation of β-catenin29,30. Intrigu-
ingly, loss of APC activates YAP by interacting with Lats1 in a
GSK-3 dependent manner50. Further, Axin regulates the Snail-
mediated epithelial-mesenchymal transition (EMT) process by
acting as a nuclear exporter of GSK-331,51. The GSK-3 shuttling
function of Axin is also required for phosphorylation of the
membranous LRP6 Wnt co-receptor and subsequent activation of
the intracellular Wnt activity52. Interestingly, we found that
soluble Wnt ligands activate YAP and subsequently decrease
afﬁnity to DVL and translocation into nuclear space. Considering
that DVL is directly regulated by Frizzled (FZD) receptors, our
observations provide an interesting mechanistic insight into
intracellular dynamics between Wnt and Hippo.
As a key scaffolding protein of the Wnt pathway, DVL relays
extracellular signals from FZD receptors to downstream effectors,
interacts with a wide range of proteins, and is involved in diverse
signaling pathways including canonical Wnt and non-canonical
PCP21,23. While the phosphorylation-dependent YAP transloca-
tion by activation of the Hippo pathway and AMPK is well
known5–8, a molecular effector regulating the YAP nuclear-
cytoplasmic shuttle has not yet been identiﬁed. We show that
NES embedded in DVL is responsible for cytoplasmic translo-
cation of phosphorylated YAP. Importantly, DVL is required for
nuclear-cytoplasmic trafﬁcking of YAP induced by contact inhi-
bition, α-catenin, E-cadherin, and metabolic stress, indicating that
Fig. 6 Loss of p53/Lats2 tumor suppressor allows co-activation of YAP and canonical Wnt activity by DVL. a The 293 cells were transfected with control
(dsRed) or shRNA for p53 (dsRed-shp53) in combination with HA-tagged DVL3 expression vector. Whole-cell lysates (WCL) were immunoblotted with
indicated antibodies, and nuclear fractions were used for nuclear YAP abundance (left panels). Endogenous YAP localization was determined by confocal
microscopy (right panels). Inset, DAPI nuclear stain; Scale bar, 10 μm. b, c The TEAD (b) or TCF/LEF (c) reporter constructs were co-transfected with YAP
and DVL3 in control transfected cell (dsRed) or shRNA for p53 transfected cells, and the relative reporter activity was measured from triplicate
experiments (mean ± SD). d The 293 cells were transfected with control (−) or mutants p53 (p53-R175H, p53-R273H) in combination with HA-tagged
DVL3 expression vector. Whole-cell lysates (WCL) were immunoblotted, and nuclear fractions were used for nuclear YAP abundance. e, f The TEAD (e)
and TCF/LEF (f) reporter construct was co-transfected with DVL in empty vector transfected cell (−) or p53 mutants transfected cells, and the relative
reporter activity was measured from triplicate experiments (mean ± SD). g The TEAD or TCF/LEF reporter constructs were co-transfected with YAP and
DVL as indicated in control transfected cell (dsRed) or shRNA for p53 transfected cells. The relative reporter activity was measured from triplicate
experiments. Data presented as mean ± SD. h The 293 cells (1 × 106) were transiently transfected with YAP and DVL3 as indicated in combination with
dsRed control or shRNA for p53, and the cells were inoculated into the ﬂank of athymic nude mice (n= 10). Tumor volume was measured 5 weeks post-
injection. Statistical signiﬁcance was determined by Mann–Whitney test. i Kaplan–Meier survival graphs for breast cancer patients with wt or mutant
p53 status on the basis of CTGF and Axin2 transcript abundances at an optimal threshold indicated by percentile numbers. Samples with high abundance
of CTGF and Axin2 are represented with red lines. See Supplementary Fig. S8c for scatter plot of CTGF and Axin2 transcript abundance. A log-rank test
was used to calculate statistical signiﬁcances
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the intracellular shuttling function of DVL is essential to various
developmental and oncogenic contexts. Previous observation
showed that knockdown of YAP resulted in nuclear accumulation
of DVL13, suggesting that the nuclear export machinery of DVL
and YAP are mutually dependent. It should be noted that 14-3-3
is required for cytoplasmic retention of phosphorylated YAP5,
and that we found DVL interacts with 14-3-3. Although the key
role of 14-3-3 in nuclear-cytoplasmic retention of phosphorylated
nuclear proteins such as cdc-25, FKHRL1, and p65-IκBα is well
known53–55, 14-3-3 itself does not have a nuclear export func-
tion54. These results, together with our observations, suggest that
14-3-3 may facilitate DVL’s nuclear export of phosphorylated
YAP. Further study is required to delineate the role of 14-3-3 in
DVL-mediated nuclear-cytoplasmic dynamics of YAP and other
phosphorylated transcriptional machinery.
The phosphorylation of YAP is important not only for its
intracellular localization but also for protein stability and binding
to other partners2. Although DVL binds and exports phos-
phorylated YAP, increased nuclear YAP by loss of DVL remained
unphosphorylated. Interestingly, Ser127 phosphorylation is
important for interaction with DVL; however, Ser127 of nuclear
YAP is still unphosphorylated in ASA mutant expressing cells,
suggesting that Ser127 phosphorylation may be reciprocally
coupled to the nuclear export function of DVL. While this study
mainly focused on nuclear-cytoplasmic trafﬁcking functions of
DVL, the role of DVL in YAP phosphorylation together with the
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Lats kinase complex in nuclear space (such as phosphorylation at
Ser109 and/or Ser381) needs further study to understand in-
depth molecular dynamics in the Hippo and Wnt pathways. It
should be noted that the modes of interaction and intracellular
function of DVL closely resemble Angiomotin (Amot) inhibiting
YAP activity26. While the Amot was identiﬁed as an angiostatin-
binding protein involved in endothelial polarization and migra-
tion, recent studies have revealed that Amot is an important
regulator of intracellular localization and nuclear YAP
activity26,56,57. Amot also harbors a conserved PY motif and C-
terminus PDZ-binding motif as do DVL and YAP,
respectively26,58. Interestingly, Amot is also phosphorylated by
Lats kinase and subsequent interaction with 14-3-356,58. Similarly
to DVL, the Amot family binds and sequesters phosphorylated
YAP2,26,56, while the nuclear export function of Amot has not yet
been determined.
PCP signaling controls polarization of cells in an epithelial
sheet via an FZD–DVL complex mediated by non-canonical Wnt
signaling. In this process, DVL (Dsh in Drosophila) and FZD play
a central role in PCP signaling, asymmetric relocalization of Dsh
and cytoskeletal reorganization of epithelial cells59. Although
many recent ﬁndings suggest that the Hippo pathway is tightly
connected with PCP in development and epithelial polarity in
mammal3,60, the molecular dynamics are largely unknown. Our
observations thus provide an interesting molecular link between
Hippo and PCP regulation in development and epithelial polarity
in human cancer. It should be noted that we could not ﬁnd
typical NES in Drosophila Dsh while there is highly conserved
NES at the distal region of the DEP domain in Ascidian and
Xenopus23. Further study is needed to identify the evolutionary
role of DVL in epithelial polarity.
The LKB1 directly regulates a number of conserved targets, the
most important being AMPK, a major sensor of cellular meta-
bolic stress45. Studies of the LKB1/AMPK axis have discovered a
novel signaling-pathway that links it with metabolism and epi-
thelial polarity. For example, activation of LKB1 by STRAD
rapidly leads to complete epithelial polarity accompanied by
remodeling of the actin cytoskeleton61, and constitutive activation
of the LKB1/AMPK axis is required for epithelial polarity and
tight junction formation regardless of cell–cell contact62–65. Note
that E-cadherin regulates AMPK activity by recruiting the LKB1/
STRAD complex at the adherens junction65,66 and that the E-
cadherin/α-catenin complex functions as a strong upstream reg-
ulator of the Hippo pathway and subcellular localization of
YAP36–38. Therefore, the molecular mechanism by which LKB1/
AMPK-dependent DVL controls epithelial polarity proteins such
as PAR, Crumbs and Scribble in development and human cancer
requires further investigation.
The tumor suppressor p53 is most frequently inactivated in
human cancer, its transcriptional activity playing key roles in
tumor suppression42,43. The transcriptional function of p53 also
suppresses canonical Wnt activity and Snail-mediated EMT by
targeting the untranslated regions of a set of genes encoding key
elements of the Wnt pathway41,44. We found that the transcrip-
tional function of p53 is also critically important in DVL’s
function on YAP trafﬁcking. Notably, p53 and Lats2 tumor
suppressors have been linked in a positive feed-forward loop by
which Lats2 strengthens p53 function, and p53 upregulates Lats2
on the transcriptional level40. Lats2 is also suppressed by an
epigenetic mechanism independent of p53 mutational status in
many types of human cancers67. The role of the LKB1/AMPK
axis on DVL’s nuclear export of YAP is especially interesting
because the LKB1 tumor suppressor is mainly associated with
metabolic aspects of human cancer. Thus, our observations pro-
vide a novel molecular mechanistic insight into the reciprocal
restriction between Wnt and YAP in a tumor suppressor context-
dependent manner.
Methods
Cell culture and immunoblot analysis. MCF-7, SK-BR-3, HCT-116, SW480,
A549, and 293 cells obtained from ATCC were routinely cultured in Dulbecco's
Modiﬁed Eagle's Medium (DMEM) medium containing 10% fetal bovine serum
(FBS). MDA-MB-231 cells (a gift from G. Mills) were cultured in a RPMI1640 with
5% FBS. MCF-10A cells (a gift from M. Wicha) were cultured in DMEM/F12 with
5% horse serum, 20 μg ml−1 EGF, 0.5 μg ml−1 hydrocortisone, 0.1 μg ml−1 cholera
toxin, 5 μg ml−1 insulin and 100 IUml−1 penicillin/streptomycin. AMPKα1/ α2
double-knockout MEF, Lats1/2 double-knockout MEF and 293A cells were kindly
provided by H. W. Park (Yonsei University, Seoul, Korea) and cultured in DMEM
medium. The wt and DVL1/2/3-triple knockout 293 T-REx cells were described
previously22. Mycoplasma infection was tested regularly with a PCR-based kit
(MP0040, Sigma). Cell lines were authenticated as described recently68. The
transfection was performed by Lipofectamine 2000 according to the manufacturer’s
protocol (Invitrogen). For the western blot analyses, protein extracts were prepared
in Triton X-100 lysis buffer. The nuclear protein abundances of YAP were deter-
mined from nuclear-cytosolic fractionation of protein lysates with hypotonic buffer
as described previously31,69. Brieﬂy, the cells (1 × 106) were collected into micro-
centrifuge tubes and treated with 400 μl of hypotonic buffer (10 mM HEPES, pH
7.9; 10 mM KCl; 1 mM dithiothreitol (DTT) with protease inhibitors) on ice for 5
min. The cell membrane was ruptured by adding 10% NP-40 to a ﬁnal con-
centration of 0.6%, then vigorously vortexed for 10 s followed by high-speed
centrifuge for 30 s. The supernatant cytosolic fractions were collected separately,
and nuclear pellets were washed with ice-cold PBS twice. Nuclear protein was
extracted with hypertonic buffer (20 mM HEPES, pH 7.9; 0.4 M NaCl; 1 mM DTT
with protease inhibitors) on ice for 15 min followed by high-speed centrifuge.
Relative nuclear YAP abundance compared to loading control HDAC1 was
determined by the ImageJ program downloaded from NIH (https://imagej.nih.gov/
ij/). Wnt1 extract and Wnt3a conditioned were prepared from RAC311-Wnt1 cells
and L-Wnt3a cell as described previously51. Antibodies against YAP (sc-101199,
Santa Cruz, 1:1,000, 1:200 for IF), phospho-S127 YAP (4911S, Cell Signaling
Technology, 1:1000), DVL1 (sc-8025, Santa Cruz, 1:1000), DVL2 (sc-8026, Santa
Cruz, 1:1000), DVL3 (sc-8027, Santa Cruz, 1:1000, 1:100 for IF), α-catenin (sc-
7894, Santa Cruz, 1:1000), Lats2 (ab70565, Abcam, 1:1000), LKB1 (sc-32245, Santa
Fig. 7 Role of LKB1/AMPK tumor suppressor axis on DVL’s function on YAP. a The MCF-10A cells expressing tetracycline-inducible shRNA against DVL3
were cultured under sparse culture condition and treated with 2-deoxyglucose (2DG, 3 mM) and metformin (Met, 5 mM) for 16 h period in absence (−) or
presence (+) of doxycycline (Dox). Endogenous YAP localization was determined by confocal microscopy. Inset, DAPI nuclear stain; Scale bar, 10 μm.
b The wt and DVL-TKO 293 T-REx cells were treated with 2DG and Met, and nuclear YAP abundance was then determined by immunoblot analysis (left
panels) and confocal microscopy (right panels). Inset, DAPI nuclear stain; Scale bar, 5 μm. c Kinase-dead GFP-fused AMPK or ﬂag-tagged LKB1 mutant was
co-transfected with control (−) or HA-tagged DVL3 (+) in 293 cells. Whole-cell lysates (WCL) were immunoblotted with indicated antibodies, and
nuclear fractions were used for nuclear YAP abundance (left panels). The TEAD (right upper) or TCF/LEF (right lower) reporter was co-transfected with
DVL in empty vector transfected cell (vector) or kinase-dead AMPK (AMPK-KD) or LKB mutant (LKB-KD), and the relative fold repression of reporter
activity was measured from triplicate experiments (mean ± SD). d The wt and AMPKα1/α2 double-knockout (DKO) MEFs were stably transfected with
inducible DVL3 and nuclear YAP abundance was examined by immunoblot analysis (left panels) and immunoﬂuorescence (right panels) in the absence
(−) or presence (+) of doxycycline for a 48 h period. Upper inset, DAPI nuclear stain; Lower inset, HA (DVL3); Scale bar, 5 μm. e The A549 cells were
stably transfected with inducible DVL3, and nuclear YAP abundance and DVL3 localization under sparse or conﬂuent culture condition were examined by
immunoblot analysis (left panels) and immunoﬂuorescence (right panels) in presence of doxycycline. Inset, DAPI nuclear stain; Scale bar, 5 μm. f The 293
cells (1 × 106) were transiently transfected with YAP and DVL3 in combination with vector control or LKB-KD mutant, and the cells were inoculated into the
ﬂank of athymic nude mice (n= 10). The empty vector or LKB-KD transfected cells served as control. Tumor volume was measured 5 weeks end-point
(Mann–Whitney test)
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Cruz, 1:1000), AMPK (2793S, Cell Signaling Technology, 1:1000), phospho-AMPK
(2535S, Cell Signaling Technology, 1:1000), HA (901501, Bio Legend, 1:2500, 1:200
for IF), p53 (sc-126, Santa Cruz, 1:1000), E-cadherin (HECD, AR17-MA0001,
AbFrontier, 1:5000, 1:500 for IF), HDAC1 (sc-7872, Santa Cruz, 1:1000), GFP (GF-
PA0043, AbFrontier, 1:1000), Flag (F-3165, Sigma, 1:5000), pan-TEAD (13295,
Cell Signaling Technology, 1:2000, 1:100 for IF) and Tubulin (LF-PA0146,
AbFrontier, 1:2500) were obtained from the commercial vendors. Phos-tag gel was
purchased from WAKO chemicals (AAL-107).
Plasmids and RNA-mediated interference. HA-tagged DVL1, DVL2, and DVL3
expression vectors were kindly provided by E. Fearon (University of Michigan).
Deletion or point mutants of DVL3 (ΔDIX, ΔPDZ, ΔDEP, NES-ASA, and ΔPDZ/
ΔPY) and YAP deletion mutants of PDZ-binding domain, WW domain and
K494R were generated by a PCR-based method. The expression vector pCMV-ﬂag-
YAP (plasmid number 19045), pCMV-ﬂag-S127A YAP (plasmid number 19050),
pCMV-ﬂag-5SA-YAP (plasmid number 27371), 3xﬂag-pCMV5-TAZ (plasmid
number 24809), pLKO1-shYAP (plasmid number 27368 and 27369), pcDNA-HA-
Lats2-K655R (kinase-dead, plasmid number 33100), pAMPK alpha2 K45R (kinase-
dead, plasmid number 15992), pBabe-LKB1-K78I (kinase-dead, plasmid number
8593), 14-3-3 gamma (plasmid number 52535) and pcDNA3-alpha-catenin
(plasmid number 24194) were obtained from Addgene. Reporter construct having
8 × wt TEAD-binding sites (plasmid number 83467), 7 ×mutant TEAD-binding
sites (plasmid number 83466), 8 × TCF/LEF-binding sites (plasmid number 12456),
and mutant-binding sites (plasmid number 12457) were obtained from Addgene.
The Tet-pLKO-puro vector (plasmid number 21915, Addgene) was used for
inducible shRNA knockdown. The target sequences of shRNA were 5′-cgacc-
cagctataagttcttcttca for human DVL3-1 and 5′-caatgacacagagacggactctttg for
human shDVL3-2. The expression vectors for shRNA against p53 and expression
vectors for HPV-E6 and mutant p53 were as described previously41. Tetracycline-
inducible wt or NES-mutant DVL3 expression vector was generated with the
pTRIPZ lentiviral system (Open Biosystems) by replacing RFP.
Immunoprecipitation and immunoﬂuorescence. For immunoprecipitation ana-
lysis, whole-cell Triton X-100 lysates were incubated with Flag-M2 agarose (Sigma)
or Ni-NTA beads (Invitrogen) and washed with lysis buffer three times. The
recovered proteins were resolved by SDS-PAGE and subjected for immunoblot
analysis. For immunoﬂuorescence study, the cells were washed twice with ice-cold
PBS and incubated for 15 min at room temperature with 3% formaldehyde in PBS.
The cells were permeabilized with 0.5% Triton X-100 for 5 min and then blocked
for 1 h in PBS containing 3% bovine serum albumin followed by incubation with
primary antibody overnight at 4 °C. Cells were then washed three times with PBS
containing 0.1% Tween 20 followed by incubation with anti-mouse-Alexa Fluor-
488 (for green) or anti-rabbit-Alexa Fluor-594 (for red) secondary antibody. Cel-
lular ﬂuorescence was monitored using confocal microscopy (Zeiss LSM780).
Functional blocking of endogenous E-cadherin complex was performed by directly
adding an HECD antibody (10 μg/ml) to normal culture medium for 16 h prior to
immunoﬂuorescence study of YAP.
Quantitative reverse transcription PCR (RT-PCR) and reporter assay. Total
RNA was isolated using TRIzol reagent (Invitrogen) following the manufacturer’s
protocol. The SuperScript III synthesis kit (Invitrogen) was used to generate
complementary DNA. Real-time quantitative PCR analysis for CTGF transcripts
was performed with an ABI-7300 instrument under standard conditions and SBGR
mix (n= 3). The expression of ΔCt value from each sample was calculated by
normalizing with GAPDH. Primer speciﬁcity and PCR process were veriﬁed by
dissociation curve after PCR reaction. The primer sequences for qPCR were 5′-
accagctcctcctcactaacc for DVL1 forward (F), 5′-tcatgtcactcttcaccgtca for DVL1
reverse (R), 5′-catgagaatctggagcctgag for DVL2-F, 5′-atgctcactgctgtctctcct for
DVL2-R, 5′-agaaggtttctcggattgagc for DVL3-F, 5′-tgttgagagtgaccgtgatga for DVL3-
R, 5′-caaaatctccaagcctatcaagtt for CTGF-F, 5′-actccacagaatttagctcggtat for CTGF-R,
5′-atgggtgtgaaccatgagaag for GAPDH-F, and 5′-agttgtcatggatgaccttgg for GAPDH-
R. For TEAD or TCF/LEF reporter assay, the cells were transfected with 50 ng of
the reporter vectors and 1 ng of pSV-Renilla expression vector in combination with
YAP and/or DVL3 as indicated. Luciferase and renilla activities were measured
using the dual-luciferase reporter system kit (Promega), and the luciferase activity
was normalized with renilla activity. The results are expressed as the averages of the
ratios of the reporter activities from triplicate experiments.
Soft agar assay. For anchorage-independent soft agar assay, cells stably transfected
with pLKO-tet-shDVL3 were suspended at 1 × 104 cells per 6-well plate with 1ml of
0.3% low-melting agar in 2 × DMEM containing 20% FBS and overlaid above a
layer of 1 ml of 1% agar in the same medium. After 2 weeks incubation with or
without doxycycline as indicated, colonies were visualized by staining with 0.05%
crystal violet in 10% ethanol for 30min and viable colonies that contained > 50 cells
were counted from ﬁve ﬁelds with a stereomicroscope. Representative colonies were
photographed and two independent experiments were performed.
Gene expression analysis of clinical samples. Publicly available mRNASeq data
of 1098 samples of breast cancer (BRCA) including long-term survival information
from The Cancer Genome Atlas (TCGA) was downloaded (https://gdac.
broadinstitute.org). The illuminahiseq_rnaseqv2-RSEM_genes_
normalized (MD5) was log2 transformed and the relative transcript abundance of
DVL homologs was compared using one-way ANOVA and Tukey’s HSD test.
Mutational status of p53 was obtained from Mutation Annotation Format (MAF)
from the Firehose website. To generate Kaplan–Meier plots, clinical samples were
grouped by p53 status and dichotomized by Axin2 and CTGF transcript abun-
dance. The scatter plots of CTGF and Axin2 abundances were obtained using R.
The high and low abundance subsets were determined based on the median
transcript abundance of CTGF and Axin2, yielding groups with the most sig-
niﬁcant differences in 20-year survival based on the log-rank test. The
Kaplan–Meier plots were then generated for the respective groups using the R
package survival.
In vivo xenograft assay. All animal experiments were performed in accordance
with guidelines of the Institutional Animal Care and Use Committee of Yonsei
University and approved by the Animal Care Committee of the Yonsei University
College of Dentistry and National Cancer Center Research Institute. Female
athymic nude mice (6-weeks-old) were used for xenograft assays into ﬂank sub-
cutaneous tissue. The 293 cells were transiently transfected with expression vectors
of DVL3 and YAP in combination with shp53 or LKB-KD as indicated prior to 48
h in vivo inoculation. The cells (1 × 106) were resuspended in 100 μl of PBS and
injected into ﬂank subcutaneous tissue. The tumorigenic capacity was measured
twice a week using a digital caliper. The mice were sacriﬁced after 5 weeks end-
point, and the tumor volume was calculated using the equation V (in mm3)= (a ×
b2)/2, where a is the longest and b the shortest diameter.
Statistical analysis. All statistical analysis of reporter assay, RT-PCR, and soft
agar assay was performed with two-tailed Student’s t-tests; data are expressed as
means and s.d. The double asterisks denote p < 0.01, one asterisk denoting p < 0.05.
Statistical signiﬁcance of animal experiments was determined using the
Mann–Whitney test. No statistical method was used to predetermine sample size.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon reasonable request.
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